Fundamentals

Valuation

Metric	Q4	Q1	Δ in %
EV/EBITDA	502.71	-858.34	142.41
Graham Fair Price	-40.89	0.39	0.66
PEG	516.79	0.97	-0.16
Price/Book	-0.67	1.72	1.73
Price/Cash Flow	7640.17	-1306.72	16.88
Prices/Earnings	176.85	-131.38	47.46
Price/Sales	8.77	15.06	13.84
Price/FCF	7640.17	-1306.72	16.88
Naive Interpretation	member

01 - Valuation · Weak

Fundamentals

Profitability

Metric	Q4	Q1	Δ in %
Gross Profit Margin	4.97	0.07	0.06
Operating Margin	-13960.53	-0.02	< 0.005
ROA	-64.78	< 0.005	< 0.005
ROE	< 0.005	< 0.005	-64.12
ROIC	< 0.005	< 0.005	-5600.69
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q4	Q1	Δ in %
Debt QOQ	0.53	-0.13	313.29
Dividends QOQ	-0.42	0.39	-7.47
EBIT QOQ	0.99	-126.98	12689.31
EPS QOQ	3.02	-1.35	-55.11
FCF QOQ	5.30	-1.01	-80.88
Revenue QOQ	0.03	-0.09	238.73
Naive Interpretation	member

03 - Financial Growth · Weak

Fundamentals

Leverage & Liquidity

Metric	Q4	Q1	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	85.77	94.89	10.64
Days Sales Outstanding (DSO)	66.81	75.09	12.40
Inventory Turnover	1.05	0.95	-9.62
Debt/Capitalization	0.05	0.08	49.55
Quick Ratio	4.55	3.94	-13.38
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q4	Q1	Δ in %
Book Value	1.46	1.44	-1.32
Cash	0.61	0.62	2.01
Capex	-0.03	< 0.005	93.10
Free Cash Flow	0.15	< 0.005	-98.73
Revenue	0.18	0.16	-9.89
Naive Interpretation	member

05 - Per Share Metrics · Weak

Fundamentals

Financial Health

Metric	Q4	Q1	Δ in %
Current Ratio	5.64	4.93	-12.52
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	-37.92	219.07	477.71
Naive Interpretation	Member

06 - Financial Health · Bad

Rating